OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+0.61%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$408M
AUM Growth
+$408M
(-18%)
Cap. Flow
-$72.9M
Cap. Flow
% of AUM
-17.86%
Top 10 Holdings %
Top 10 Hldgs %
91.49%
Holding
23
New
1
Increased
5
Reduced
6
Closed
3
Top Buys
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$3.34M |
| 2 |
Pacific Biosciences
PACB
|
$2.22M |
| 3 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$2.22M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$1.34M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$593K |
Top Sells
| 1 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$64.2M |
| 2 |
AXDX
Accelerate Diagnostics
AXDX
|
$3.88M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$3.39M |
| 4 |
QuidelOrtho
QDEL
|
$2.7M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$2.66M |
Sector Composition
| 1 | Healthcare | 96.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
QuidelOrtho
QDEL
$1.95B
| $121M | 29.33% | 2,336,448 -52,100 | -2% | -$2.7M |
|
|
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
| $102M | 24.62% | 4,447,618 -169,719 | -4% | -$3.88M |
|
|
TSRO
3
DELISTED
TESARO, Inc.
TSRO
| $48.3M | 11.69% | 844,718 -46,524 | -5% | -$2.66M |
|
|
4
Pacific Biosciences
PACB
$393M
| $19.6M | 4.74% | 9,537,661 +1,084,286 | +13% | +$2.22M |
|
|
AMRN
5
Amarin Corp
AMRN
$311M
| $15.6M | 3.78% | 5,176,479 -1,126,828 | -18% | -$3.39M |
|
|
MZOR
6
DELISTED
Mazor Robotics Ltd.
MZOR
| $15.1M | 3.66% | 246,317 -1,046,459 | -81% | -$64.2M |
|
|
ADAP
7
Adaptimmune Therapeutics
ADAP
$15.6M
| $14.9M | 3.62% | 1,330,070 +297,349 | +29% | +$3.34M |
|
|
VRML
8
DELISTED
Vermillion, Inc.
VRML
| $13.4M | 3.24% | 9,825,289 | – | – |
|
|
BIOL
9
DELISTED
Biolase, Inc.
BIOL
| $12.5M | 3.04% | 30,866,262 | – | – |
|
10
Opko Health
OPK
$1.1B
| $11.7M | 2.83% | 3,686,194 -140,566 | -4% | -$446K |
|
|
AGEN
11
Agenus
AGEN
$133M
| $7.29M | 1.77% | 1,547,392 | – | – |
|
|
EPZM
12
DELISTED
Epizyme, Inc
EPZM
| $7.04M | 1.7% | 396,325 +33,433 | +9% | +$593K |
|
|
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $6.89M | 1.67% | 174,525 +33,859 | +24% | +$1.34M |
|
|
CFRX
14
DELISTED
ContraFect Corporation
CFRX
| $5.15M | 1.25% | 3,167,013 +266,596 | +9% | +$433K |
|
15
Soleno Therapeutics
SLNO
$3.6B
| $4.33M | 1.05% | 2,388,060 | – | – |
|
|
KDNY
16
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.22M | 0.54% | +238,478 | New | +$2.22M |
|
17
Biogen
BIIB
$19.4B
| $1.74M | 0.42% | 6,368 | – | – |
|
18
Vivani Medical
VANI
$68.1M
| $98K | 0.02% | 50,804 | – | – |
|
19
Accuray
ARAY
$157M
| – | – | -376,799 | Closed | -$1.62M |
|
20
Bristol-Myers Squibb
BMY
$96B
| – | – | 0 | – | – |
|
21
Precigen
PGEN
$1.34B
| – | – | -195,000 | Closed | -$2.25M |
|
|
ELGX
22
DELISTED
Endologix Inc
ELGX
| – | – | -362,727 | Closed | -$1.94M |
|
|
NXTM
23
DELISTED
NxStage Medical Inc.
NXTM
| – | – | 0 | – | – |
|